Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Appointed director
Neuro-Hitech, Inc. (NHPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/13/2009 8-K Quarterly results
07/27/2009 8-K Form 8-K -- Current report
03/30/2009 8-K Form 8-K -- Current report
01/13/2009 8-K Form 8-K -- Current report
07/11/2008 8-K Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Moore Stephens, P.C., regarding change in independent registered public accounting firm"
06/30/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
06/11/2008 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Agreement and Plan of Merger, by and among Neuro-Hitech, Inc., GKI Acquisition Sub, Inc., GKI Acquisition Corporation and Timothy J. Ryan, Matthew Colpoys, Jr. and Philip J. Young",
"Amended and Restated Stock Purchase Agreement, by and among, Neuro-Hitech, Inc., GKI Acquisition Corporation, and David Ambrose",
"Securities Purchase Agreement, by and among Neuro-Hitech, Inc. and each of the investors identified therein",
"Consulting Agreement, by and among Neuro-Hitech, Inc. and David Ambrose",
"Resignation Agreement and Mutual Release, by and among Neuro-Hitech, Inc. and Gary T. Shearman",
"Employment Agreement between NHI and Matthew E. Colpoys",
"Closes on Equity Raise"
03/28/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Neuro-Hitech Receives Notice of Delisting from NASDAQ"
03/20/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Neuro-Hitech Receives Delisting Warning Letter from NASDAQ"
03/07/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "BAU Analysis and Partnering Letter of Intent",
"Neuro-Hitech, Inc. Announces Agreement with Numoda Corporation to Progress Development of Huperzine A in Alzheimer's Disease"
02/22/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Neuro-Hitech Receives Delisting Warning Letter from NASDAQ"
02/01/2008 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Neuro-Hitech Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer’s Disease Patients"
01/09/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Letter to the Company’s stockholders"
01/02/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Amended and Restated Non-Management Directors Deferral Program"
12/19/2007 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Stock and Warrant Purchase Agreement, by and among Neuro-Hitech, Inc. and the investors identified therein",
"Registration Rights Agreement, by and among Neuro-Hitech, Inc. and the investors identified therein",
"Form of Warrant issued in connection with the Offering"
12/11/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Employment Agreement between Neuro-Hitech, Inc. and David Barrett"
11/29/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Neuro-Hitech Announces Private Offering of $5.0 Million"
10/04/2007 8-K Other Events
09/25/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "NEURO-HITECH DIRECTOR TERMINATES RULE 10b5-1 PLAN - September 25, 2007 -- Neuro-Hitech, Inc. , a biopharmaceutical company focused on the development and commercialization of next-generation compounds for neurodegenerative diseases, today announced that Alan Kestenbaum, a director and founder of the company, terminated a pre-arranged stock trading plan previously adopted by him in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Transactions under the stock trading plan were publicly disclosed through Form 144 and Form 4 filings with the Securities and Exchange Commission. About Neuro-Hitech, Inc."
09/18/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "NEURO-HITECH DIRECTOR ADOPTS RULE 10b5-1 PLAN - September 18, 2007 -- Neuro-Hitech, Inc. , a biopharmaceutical company focused on the development and commercialization of next-generation compounds for neurodegenerative diseases, today announced that Alan Kestenbaum, a director and founder of the company, established a pre-arranged stock trading plan, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Rule 10b5-1 permits individuals who are not in possession of material, non-public information at the time the plan is adopted to establish pre-arranged plans to buy or sell company stock. Using these plans, individuals can prudently and gradually diversify their investment portfolios over an extended period of time. Mr. Kestenbaum has authorized the sale of up t..."
08/29/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Employment Agreement between Neuro-Hitech, Inc. and Gary Shearman",
"Indemnity Agreement between Neuro-Hitech, Inc. and Gary Shearman",
"Neuro-Hitech Announces the Appointment of Dr. Gary Shearman as President and Chief Executive Officer"
07/02/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
04/24/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Neuro-Hitech Begins Trading on the NASDAQ Capital Market"
03/26/2007 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Neuro-Hitech Announces Final Closing of $5.6 Million Equity Private Placement"
02/15/2007 8-K Appointed a new director
12/05/2006 8-K Entered into consulting agreement
Docs: "Agreement and Plan of Merger, by and among Neuro-Hitech, Inc., QA Acquisition Corp., QA Merger LLC, Q-RNA, Inc., and Dr. David Dantzker, as the Representative of the Q-RNA, Inc. security holders",
"Securities Purchase Agreement, by and among Neuro-Hitech, Inc. and the investors identified therein",
"Registration Rights Agreement, by and among Neuro-Hitech, Inc. and David Dantzker as the Representative of the Q-RNA, Inc. security holders",
"NEURO-HITECH, INC. REGISTRATION RIGHTS AGREEMENT",
"Form of $13 Warrant issued pursuant to the Merger",
"Form of $18 Warrant issued pursuant to the Merger",
"Form of Warrant issued in connection with the Private Offering",
"Amendment No. 1 to 2006 Incentive Stock Plan",
"Amendment No. 2 to 2006 Incentive Stock Plan"
11/17/2006 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Neuro-Hitech Announces Agreement to Acquire Q-RNA, Inc., Acquisition Will Greatly Expand Neuro-Hitech’s Pipeline; Focus Now On Broader Range of Neurodegenerative Diseases, Including Alzheimer’s, Epilepsy, Parkinson’s"
08/11/2006 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Ownership and Merger effective August 11, 2006"
04/07/2006 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Neuro-Hitech Pharmaceuticals, Inc. Appoints David Barrett Chief Financial Officer"
03/21/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "NEURO-HITECH PHARMACEUTICALS, INC. SIGNS ALZHEIMER’S TRANSDERMAL DEVELOPMENT AGREEMENT WITH XEL"
02/07/2006 8-K Entry into a Material Definitive Agreement
01/30/2006 8-K Entry into a Material Definitive Agreement
Docs: "AGREEMENT OF MERGER AND PLAN OF REORGANIZATION",
"OF MARCO ACQUISITION I, INC. A DELAWARE CORPORATION WITH AND INTO MARCO HI-TECH JV LTD. A NEW YORK CORPORATION",
"STATE OF DELAWARE CERTIFICATE OF MERGER OF MARCO ACQUISITION I, INC. A DELAWARE CORPORATION WITH AND INTO MARCO HI-TECH JV LTD. A NEW YORK CORPORATION",
"STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION",
"001 MARCO HI-TECH JV LTD.",
"4.2 THIS WARRANT AND ANY SECURITIES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED",
"MARCO HI-TECH JV LTD. 100,000 SHARES WARRANT TO PURCHASE COMMON STOCK VOID AFTER 5:30 P.M., EASTERN STANDARD TIME, ON THE EXPIRATION DATE THIS WARRANT AND ANY SHARES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED",
"10.1 NEUROTECH PHARMACEUTICALS, INC. 2006 INCENTIVE STOCK PLAN 1. PURPOSE OF THE PLAN.",
"10.2 NEUROTECH PHARMACEUTICALS, INC. 2006 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN 1. PURPOSE OF THE PLAN."
01/23/2006 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Agreement and Plan of Merger, between Northern Way Resources, Inc., a Nevada corporation, and Northern Way Resources, Inc., a Delaware corporation",
"Certificate of Ownership and Merger merging Northern Way Resources, Inc. a Nevada corporation, into Northern Way Resources., Inc., a Delaware corporation",
"Articles of Merger merging Northern Way Resources, Inc., a Nevada corporation, into Northern Way Resources, Inc., a Delaware corporation",
"Certificate of Incorporation of Neurotech Pharmaceuticals, Inc",
"By-laws of Neurotech Pharmaceuticals, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy